RT Journal Article
SR Electronic
A1 Rizzo, Toni
T1 HTN Guidelines Favor Combination Therapy for HTN Management
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 24
SP 31
OP 32
DO 10.1177/155989771424023
UL http://mdc.sagepub.com/content/14/24/31.abstract
AB Blood pressure (BP) is a surrogate that is treated to prevent cardiovascular disease (CVD) and its consequences. However, outside of clinical trials, it is difficult to know how these outcomes are affected by antihypertensive therapy. Although clinical trials provide useful information, they do not give the full picture. Real-life practice is more complicated than clinical trials, but both need to be considered in managing hypertension (HTN). This article discusses the new international guidelines for the management of HTN were issued in Europe and the United States in 2013.